BACKGROUND: A reverse epidemiology of classic cardiovascular risk factors was observed in hemodialysis patients with a high comorbidity burden. We hypothesized that uric acid, a novel cardiovascular risk factor, also has an altered association with survival in these patients. METHODS: A retrospective study was conducted on 168 consecutive outpatient hemodialysis patients over a 6-year period. Serum uric acid, albumin levels and relevant laboratory information were recorded monthly. The disease severity was assessed using Comorbidity Index (CoI) scores. Patients were stratified into 3 groups according to their serum uric acid concentrations: group I was the lowest quintile, group II was the middle 3 quintiles and group III was the highest quintile. The risks of death were calculated utilizing a Cox regression model. RESULTS: Using group II as a reference group, the hazard ratio of group I was 2.23 [95% confidence interval (CI) 1.21-4.11, p = 0.01] and group III was 0.89 (95% CI 0.47-1.71, p = 0.74). The serum uric acid levels correlated inversely with CoI scores (r = -0.31, 95% CI -0.44 to -0.17, p < 0.0001) and positively with serum albumin levels (r = 0.35, 95% CI 0.21-0.48, p < 0.0001). CONCLUSION: Low serum uric acid is a mortality risk factor in incident hemodialysis patients with a high comorbidity burden and hypoalbuminemia. Copyright (c) 2008 S. Karger AG, Basel.
BACKGROUND: A reverse epidemiology of classic cardiovascular risk factors was observed in hemodialysis patients with a high comorbidity burden. We hypothesized that uric acid, a novel cardiovascular risk factor, also has an altered association with survival in these patients. METHODS: A retrospective study was conducted on 168 consecutive outpatient hemodialysis patients over a 6-year period. Serum uric acid, albumin levels and relevant laboratory information were recorded monthly. The disease severity was assessed using Comorbidity Index (CoI) scores. Patients were stratified into 3 groups according to their serum uric acid concentrations: group I was the lowest quintile, group II was the middle 3 quintiles and group III was the highest quintile. The risks of death were calculated utilizing a Cox regression model. RESULTS: Using group II as a reference group, the hazard ratio of group I was 2.23 [95% confidence interval (CI) 1.21-4.11, p = 0.01] and group III was 0.89 (95% CI 0.47-1.71, p = 0.74). The serum uric acid levels correlated inversely with CoI scores (r = -0.31, 95% CI -0.44 to -0.17, p < 0.0001) and positively with serum albumin levels (r = 0.35, 95% CI 0.21-0.48, p < 0.0001). CONCLUSION: Low serum uric acid is a mortality risk factor in incident hemodialysis patients with a high comorbidity burden and hypoalbuminemia. Copyright (c) 2008 S. Karger AG, Basel.
Authors: Mohamed E Suliman; Richard J Johnson; Elvia García-López; A Rashid Qureshi; Hadi Molinaei; Juan Jesús Carrero; Olof Heimbürger; Peter Bárány; Jonas Axelsson; Bengt Lindholm; Peter Stenvinkel Journal: Am J Kidney Dis Date: 2006-11 Impact factor: 8.860
Authors: Chi-yuan Hsu; Charles E McCulloch; Carlos Iribarren; Jeanne Darbinian; Alan S Go Journal: Ann Intern Med Date: 2006-01-03 Impact factor: 25.391
Authors: Kamyar Kalantar-Zadeh; Tamara B Horwich; Antigone Oreopoulos; Csaba P Kovesdy; Houman Younessi; Stefan D Anker; John E Morley Journal: Curr Opin Clin Nutr Metab Care Date: 2007-07 Impact factor: 4.294
Authors: Juan Jesús Carrero; Abdul Rashid Qureshi; Jonas Axelsson; Carla María Avesani; Mohammed E Suliman; Sawako Kato; Peter Bárány; Sunna Snaedal-Jonsdottir; Anders Alvestrand; Olof Heimbürger; Bengt Lindholm; Peter Stenvinkel Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Walead Latif; Angelo Karaboyas; Lin Tong; James F Winchester; Charlotte J Arrington; Ronald L Pisoni; Mark R Marshall; Werner Kleophas; Nathan W Levin; Ananda Sen; Bruce M Robinson; Rajiv Saran Journal: Clin J Am Soc Nephrol Date: 2011-08-25 Impact factor: 8.237
Authors: Mehmet Kanbay; Mustafa Ikizek; Yalcin Solak; Yusuf Selcoki; Sema Uysal; Ferah Armutcu; Beyhan Eryonucu; Adrian Covic; Richard J Johnson Journal: Am J Nephrol Date: 2011-03-10 Impact factor: 3.754
Authors: Sunil V Badve; Fiona Brown; Carmel M Hawley; David W Johnson; John Kanellis; Gopala K Rangan; Vlado Perkovic Journal: Nat Rev Nephrol Date: 2011-02-15 Impact factor: 28.314
Authors: Douglas M Silverstein; Poyyapkam R Srivaths; Parnell Mattison; Kiran Upadhyay; Laurie Midgley; Asha Moudgil; Stuart L Goldstein; Daniel I Feig Journal: Pediatr Nephrol Date: 2011-04-10 Impact factor: 3.714